The axillary lymph node (AX) region is the principal site for metastatic spread from carcinoma of the breast. The second major site of regional metastases is the internal mammary lymph node (IM) chain. It is well known that histologic presence or absence of AX and/or IM is a crucial diagnostic parameter for the prognosis of the breast cancer patients (Veronesi et al., 1985; Noguchi et al., 1991 (Leathem et al., 1984; Fenlon et al., 1987; Alam et al., 1990 Postoperatively, lymph nodes were removed from the resected specimens. The average total number of dissected axillary lymph nodes per patients was 26 nodes, with a range of 12-105. At least three sections were made of each lymph node for histological examination with Hematoxylin and Eosin staining. There were 53 patients with negative AX, 20 with one to three positive AX, and 25 with four or more positive AX. IM were positive in 17 patients and negative in 81 patients.
The axillary lymph node (AX) region is the principal site for metastatic spread from carcinoma of the breast. The second major site of regional metastases is the internal mammary lymph node (IM) chain. It is well known that histologic presence or absence of AX and/or IM is a crucial diagnostic parameter for the prognosis of the breast cancer patients (Veronesi et al., 1985; Noguchi et al., 1991) . Since there is a trend towards more conservative forms of breast surgery in many centers, however, AX or IM status remains unknown for most patients. For these reasons, there is a clear need for the development of accurate prognostic indices which do not involve AX and/or IM dissection.
Alterations in cell surface carbohydrates have been related to metastatic potential of experimental tumours and correlated with high and low metastatic sublines (Altevogt et al., 1983; Steck et al., 1983) . Lectins are proteins from different origins which bind to carbohydrate groups. Among these proteins, Brooks et al. (1991) suggested that Helix pomatia agglutinin (HPA) might provide valuable information in breast cancer patients in whom AX dissection has not been preformed, because there is a significant relationship between the HPA staining and AX metastases (Leathem et al., 1984; Fenlon et al., 1987; Alam et al., 1990 Postoperatively, lymph nodes were removed from the resected specimens. The average total number of dissected axillary lymph nodes per patients was 26 nodes, with a range of 12-105. At least three sections were made of each lymph node for histological examination with Hematoxylin and Eosin staining. There were 53 patients with negative AX, 20 with one to three positive AX, and 25 with four or more positive AX. IM were positive in 17 patients and negative in 81 patients.
The method for preparation of the paraffin sections for HPA staining has been described elsewhere (Fukutomi et al., 1989) . Most cases were clearly either intensively positive or completely negative. In a few cases we used the scoring defined by Brooks et al. (1991) . Finally cases were classified as positive or negative staining.
Statistically, a comparison was made using the chi-square test. In the univariate study, overall or disease-free survival was studied by the Kaplan-Meier method (Kaplan & Meier, 1958) , and a log-rank test was used to assess statistical significance. In the multivariate study, Cox's regression test was used to examine several parameters simultaneously, followed by multiple regression analysis to determine which variables are important for predicting AX or IM metastases. From the coefficients of variables selected by a stepwise forward selection method, we were able to construct the following discriminant function. Discriminant score (Z) = a. + a,X, +. ..... + apXp, (a.; constant; al, a2.ap: discriminant coefficient; XI, X2. Xp: explanatory variables). The probability (P) of positive AX or IM was calculated by the following logistic function: P = ez/(1 + ez) = 1/(1 + e-z), e = 2.718.-). For predicting the AX or IM metastases, Z>0 (P>0.5) was regarded as positive AX or IM, and Z.0 (P<0.5) as negative AX or IM.
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Forty-four (45%) of the 98 breast cancers were HPA-positive, and the remaining 54 (55%), HPA-negative. The positive rates of HPA staining were significantly higher as the disease progressed, with 7% for Stage 1, 42% for Stage 2, and 69% for Stage 3 (P<0.01). Moreover, HPA staining was found to be significantly associated with tumour size Figure 1 . In prediction of AX metastases by discriminant function with clinical variables alone, consequently, an accuracy of 79%, a sensitivity of 69%, and a specificity of 87% were achieved. In prediction of IM metastases by discriminant function with clinical variables alone, these values were 74%, 71% and 75%, respectively. When HPA staining was regarded as an indicator of AX metastases, a diagnostic accuracy of 72%, a sensitivity of 69% and a specificity of 75% were achieved. When regarded as an indicator of IM metastases, these values became 64%, 76% and 62%, respectively. These predictive values were weakly but not significantly improved by both clinical variables and HPA staining as compared to CV alone (Table TI) .
When all the prognostic variables were examined individually in the univariate study (Table III) , tumour size, HPA staining, AX and IM metastases were significant factors for overall and disease-free survival. When all variables were considered simultaneously in multivariate analysis (Table III) to identify which variables conveyed unique prognostic information, only AX and IM metastases were significant factors for both overall and disease-free survival, while HPA staining did not appear to be significant independent prognostic factor. This actually emphasised a significant association between HPA staining and AX or IMN metastases.
Discussion
Not only the management of IM metastases (Veronesi & Valagussa, 1981; Lacour et al., 1987; Meier et al., 1989) , but also that of AX metastases (Kinne, 1983; Fisher et al., 1985; Yang et al., 1987) has been controversial in operable breast cancer patients. As an unanimous principle, AX should be dissected in clinically AX-positive patients. However, the need for immediate AX dissection in clinically AX-negative patients has been questioned (Cascinelli et al., 1987) , because immediate AX dissection did not show any superiority in terms of survival compared to AX dissection performed only when clinical AX metastases appeared in a randomised clinical study (Fisher et al., 1985) . The main reason for AX dissection in clinically AX-negative patients is the staging of breast cancer, but the chances that AX are involved is only of the order of 20-25% in those patients (Noguchi et al., 1991) . On the other hand, it has also been reported that information about the presence or absence of IM metastases is important for estimating the prognosis of breast cancer patients (Veronesi et al., 1985; Noguchi et al., 1991) . Nevertheless, routine IM dissection has not been justified as a staging procedure, because IM are involved only in 20% of the patients with operable breast cancer. If AX and/or IM metastases can be accurately estimated by biological parameters, then, dissection of AX and/or IM can be avoided in some breast cancer patients. Leathem et al. (1984 Leathem et al. ( , 1985 Leathem et al. ( , 1987 found that lectin from the albumin gland of the Roman snail, Helix pomatia agglutinin (HPA), which recognises N-acetyl-galactosaminyl residues, binds to a population of breast-cancer cells associated with AX metastases. Other investigators (Fenlon et al., 1987; Alam et al., 1990; Brooks & Leathem, 1991) also reported that the presence of HPA binding correlated with AX metastases, whereas it has also been reported (Fukutomi et al., 1989; Galea et al., 1991) Brooks et al. (1991) and our may have some bearing on the significance of the HPA staining, although the incidence of HPA staining (45%) was similar with the incidence of AX metastases (46%) in this study. Since it is troublesome for clinicians to calculate the discriminant function for each patient, and one of the principal factors included in the discriminant function was clinical axillary status, however, the usefulness of the discriminant function would be limited. HPA staining would be a more realistic alternative in the clinical setting.
Nevertheless, either HPA staining or the discriminant function was shown to be inaccurate with an accuracy of less than 80%. They are still far from satisfactory. In this study, it was confirmed that the histological status of AX and IM can provide important prognostic information in breast cancer patients. Therefore, it was concluded that AX dissection and biopsy of IM are important in the detection of regional lymph node metastases (Fentiman et al., 1991; Noguchi et al., 1991) .
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